참고문헌 질염 편집하기

# Mead PB. Epidemiology of bacterial vaginosis. Am J Obstet Gynecol 1993;169(2 Pt 2):446-449.
# [[질염#cite ref-Bacterial vaginosis in a family practice population. 2-0|이동↑]] Schmidt H, Hansen JG. Bacterial vaginosis in a family practice population. Acta Obstet Gynecol Scand 2000;79:999-1005.
# [[질염#cite ref-Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV 3-0|이동↑]] Taha TE, Hoover DR, Dallabetta GA, et al. Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS 1998;12:1699-1706.
# [[질염#cite ref-Vaginal lactobacilli.2C microbial flora.2C and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. 4-0|이동↑]] Martin HL, Richardson BA, Nyange PM, et al. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis 1999;180:1863-1838.
# ↑ <sup>[[질염#cite ref-Management of patients with recurrent vulvovaginal candidiasis. 5-0|이동:5.0]]</sup> <sup>[[질염#cite ref-Management of patients with recurrent vulvovaginal candidiasis. 5-1|5.1]]</sup> <sup>[[질염#cite ref-Management of patients with recurrent vulvovaginal candidiasis. 5-2|5.2]]</sup> <sup>[[질염#cite ref-Management of patients with recurrent vulvovaginal candidiasis. 5-3|5.3]]</sup> Sobel JD. Management of patients with recurrent vulvovaginal candidiasis. Drugs 2003;63:1059-1066.
# ↑ <sup>[[질염#cite ref-Bacterial vaginosis as a risk factor for preterm delivery: a meta-analysis. 6-0|이동:6.0]]</sup> <sup>[[질염#cite ref-Bacterial vaginosis as a risk factor for preterm delivery: a meta-analysis. 6-1|6.1]]</sup> Leitich H, Bodner-Adler B, Brunbauer M, et al. Bacterial vaginosis as a risk factor for preterm delivery: a meta-analysis. Am J Obstet Gynecol 2003;189:139-147.
# [[질염#cite ref-Bacterial vaginosis and trichomoniasis vaginitis are risk factors for cuff cellulitis after abdominal hysterectomy. 7-0|이동↑]] Soper DE, Bump RC, Hurt WG. Bacterial vaginosis and trichomoniasis vaginitis are risk factors for cuff cellulitis after abdominal hysterectomy. Am J Obstet Gynecol 1990;163:1016-1021.
# [[질염#cite ref-A randomised comparison of strategies for reducing infective complications of induced abortion. 8-0|이동↑]] Penney GC, Thompson M, Norman J, et al. A randomised comparison of strategies for reducing infective complications of induced abortion. Br J Obstet Gynaecol 1998; 105:599-604.
# [[질염#cite ref-Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. 9-0|이동↑]] Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991;29:297-301.
# [[질염#cite ref-Screening for Trichomonas vaginalis in high-risk adolescent females with a new transcription- mediated nucleic acid amplification test .28NAAT.29: associations with ethnicity.2C symptoms.2C and prior and current STIs 10-0|이동↑]] Hollman D, Coupey SM, Fox AS, et al. Screening for Trichomonas vaginalis in high-risk adolescent females with a new transcription- mediated nucleic acid amplification test (NAAT): associations with ethnicity, symptoms, and prior and current STIs. J Pediatr Adolesc Gynecol 2010;23:312–6.
# [[질염#cite ref-Changing sexually transmitted infection screening protocol will result in improved case finding for Trichomonas vaginalis among high-risk female populations. 11-0|이동↑]] Roth AM, Williams JA, Ly R, et al. Changing sexually transmitted infection screening protocol will result in improved case finding for Trichomonas vaginalis among high-risk female populations. Sex Transm Dis 2011;38:398–400.
# [[질염#cite ref-Molecular testing for Trichomonas vaginalis in women: results from a prospective U.S. clinical trial. 12-0|이동↑]] Schwebke JR, Hobbs MM, Taylor SN, et al. Molecular testing for Trichomonas vaginalis in women: results from a prospective U.S. clinical trial. J Clin Microbiol 2011;49:4106–11.
# [[질염#cite ref-Comparison of APTIMA Trichomonas vaginalis transcription-mediated amplification to wet mount microscopy.2C culture.2C and polymerase chain reaction for diagnosis of trichomoniasis in men and women. 13-0|이동↑]] Nye MB, Schwebke JR, Body BA. Comparison of APTIMA Trichomonas vaginalis transcription-mediated amplification to wet mount microscopy, culture, and polymerase chain reaction for diagnosis of trichomoniasis in men and women. Am J Obstet Gynecol 2009;200:e181–7.
# [[질염#cite ref-Rapid antigen testing compares favorably with transcription-mediated amplification assay for the detection of Trichomonas vaginalis in young women. 14-0|이동↑]] Huppert JS, Mortensen JE, Reed JL, et al. Rapid antigen testing compares favorably with transcription-mediated amplification assay for the detection of Trichomonas vaginalis in young women. Clin Infect Dis 2007;45:194–8.
# [[질염#cite ref-Comparison of different metronidazole therapeutic regimens for bacterial vaginosis. 15-0|이동↑]] Lugo-Miro V, Green M, Mazur L. Comparison of different metronidazole therapeutic regimens for bacterial vaginosis. A meta-analysis. JAMA 1992;268:92-95.
# [[질염#cite ref-Metronidazole for bacterial vaginosis. A comparison of vaginal gel vs. oral therapy. 16-0|이동↑]] Hanson JM, McGregor JA, Hillier SL, et al. Metronidazole for bacterial vaginosis. A comparison of vaginal gel vs. oral therapy. J Reprod Med 2000;45:889-896.
# [[질염#cite ref-Comparison of single-dose vs one-week course of metronidazole for symptomatic bacterial vaginosis. 17-0|이동↑]] Swedberg J, Steiner JF, Deiss F, Steiner S, Driggers DA. Comparison of single-dose vs one-week course of metronidazole for symptomatic bacterial vaginosis. JAMA 1985;254:1046-1049.
# [[질염#cite ref-Treatment of bacterial vaginosis: a comparison of oral metronidazole.2C metronidazole vaginal gel.2C and clindamycin vaginal cream. 18-0|이동↑]] Ferris DS, Litaker MS, Woodward L, Mathis D, Hendrich J. Treatment of bacterial vaginosis: a comparison of oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream. J Fam Pract 1995;41:443-449.
# [[질염#cite ref-Vaginitis. 19-0|이동↑]] Sobel JD. Vaginitis. N Engl J Med 1997;337:1896-1903.
# [[질염#cite ref-Bacterial vaginosis. 20-0|이동↑]] Sobel J. Bacterial vaginosis. Annu Rev Med 2000;51:349-356.
# [[질염#cite ref-What is the best approach for managing recurrent bacterial vaginosis.3F 21-0|이동↑]] Alfonsi GA, Shlay JC, Parker S, et al. What is the best approach for managing recurrent bacterial vaginosis? J Fam Pract 2004;53:650-652.
# ↑ <sup>[[질염#cite ref-Screening for bacterial vaginosis in pregnancy. 22-0|이동:22.0]]</sup> <sup>[[질염#cite ref-Screening for bacterial vaginosis in pregnancy. 22-1|22.1]]</sup> Guise JM, Mahon SM, Aickin M, et al. Screening for bacterial vaginosis in pregnancy. Am J Prev Med 2001;20(Suppl 3):62-72.
# ↑ <sup>[[질염#cite ref-Antibiotics for treating bacterial vaginosis in pregnancy. 23-0|이동:23.0]]</sup> <sup>[[질염#cite ref-Antibiotics for treating bacterial vaginosis in pregnancy. 23-1|23.1]]</sup> <sup>[[질염#cite ref-Antibiotics for treating bacterial vaginosis in pregnancy. 23-2|23.2]]</sup> McDonald H, Brocklehurst P, Parsons J, et al. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev 2003;2:CD000262. 인용 오류: 잘못된 <code><nowiki><ref></nowiki></code> 태그; "Antibiotics for treating bacterial vaginosis in pregnancy."이 다른 콘텐츠로 여러 번 정의되었습니다
# ↑ <sup>[[질염#cite ref-Prenatal use of metronidazole and birth defects: no association. 24-0|이동:24.0]]</sup> <sup>[[질염#cite ref-Prenatal use of metronidazole and birth defects: no association. 24-1|24.1]]</sup> Piper JM, Mitchel EF, Ray WA. Prenatal use of metronidazole and birth defects: no association. Obstet Gynecol 1993;82:348-352.
# ↑ <sup>[[질염#cite ref-A population based case-control teratologic study of oral metronidazole. 25-0|이동:25.0]]</sup> <sup>[[질염#cite ref-A population based case-control teratologic study of oral metronidazole. 25-1|25.1]]</sup> Czeizel A, Rockenbauer M. A population based case-control teratologic study of oral metronidazole. Br J Obstet Gynaecol 1998;105:322-327.
# ↑ <sup>[[질염#cite ref-Safety of metronidazole in pregnancy: a meta-analysis. 26-0|이동:26.0]]</sup> <sup>[[질염#cite ref-Safety of metronidazole in pregnancy: a meta-analysis. 26-1|26.1]]</sup> Burtin P, Taddio A, Ariburnu O, Einarson TR, Koren G. Safety of metronidazole in pregnancy: a metaanalysis. Am J Obstet Gynecol 1995;172(2 Pt 1):525-529. 인용 오류: 잘못된 <code><nowiki><ref></nowiki></code> 태그; "Safety of metronidazole in pregnancy: a meta-analysis."이 다른 콘텐츠로 여러 번 정의되었습니다
# ↑ <sup>[[질염#cite ref-Is metronidazole teratogenic.3F A meta-analysis. 27-0|이동:27.0]]</sup> <sup>[[질염#cite ref-Is metronidazole teratogenic.3F A meta-analysis. 27-1|27.1]]</sup> Caro-Paton T, Carvajal A, Martin de Diego I, et al. Is metronidazole teratogenic? A meta-analysis. Br J Clin Pharmacol 1997;44:179-182.
# ↑ <sup>[[질염#cite ref-Metronidazole excretion in human milk and its effect on the suckling neonate. 28-0|이동:28.0]]</sup> <sup>[[질염#cite ref-Metronidazole excretion in human milk and its effect on the suckling neonate. 28-1|28.1]]</sup> Passmore CM, McElnay JC, Rainey EA, D’Arcy PF. Metronidazole excretion in human milk and its effect on the suckling neonate. Br J Clin Pharmacol 1988;26:45-51.
# ↑ <sup>[[질염#cite ref-Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis .28thrush.29. 29-0|이동:29.0]]</sup> <sup>[[질염#cite ref-Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis .28thrush.29. 29-1|29.1]]</sup> Watson MC, Grimshaw JM, Bond CM, et al. Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (thrush). Cochrane Database Syst Rev 2001;4:CD002845.
# [[질염#cite ref-Treatment of complicated Candida vaginitis: comparison of single and sequential doses of fluconazole. 30-0|이동↑]] Sobel JD, Kapernick PS, Zervos M, et al. Treatment of complicated Candida vaginitis: comparison of single and sequential doses of fluconazole. Am J Obstet Gynecol 2001;185:363-369.
# ↑ <sup>[[질염#cite ref-Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. 31-0|이동:31.0]]</sup> <sup>[[질염#cite ref-Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. 31-1|31.1]]</sup> Sobel JD, Wiesenfeld HC, Martens M, et al. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. N Engl J Med 2004;351:876-883.
# ↑ <sup>[[질염#cite ref-Vulvovaginal candidiasis: epidemiologic.2C diagnostic.2C and therapeutic considerations. 32-0|이동:32.0]]</sup> <sup>[[질염#cite ref-Vulvovaginal candidiasis: epidemiologic.2C diagnostic.2C and therapeutic considerations. 32-1|32.1]]</sup> Sobel JD, Faro S, Force RW, et al. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. Am J Obstet Gynecol 1998;178:203-211.
# [[질염#cite ref-Single oral dose fluconazole compared with conventional clotrimazole topical therapy of Candida vaginitis. 33-0|이동↑]] Sobel JD, Brooker D, Stein GE, et al. Single oral dose fluconazole compared with conventional clotrimazole topical therapy of Candida vaginitis. Fluconazole Vaginitis Study Group. Am J Obstet Gynecol 1995;172(4 Pt 1):1263-1268.
# [[질염#cite ref-Practice guidelines for the treatment of candidiasis. 34-0|이동↑]] Rex JH, Walsh TJ, Sobel JD, et al. Practice guidelines for the treatment of candidiasis. Clin Infect Dis 2000;30:662-678.
# [[질염#cite ref-Recurrent vulvovaginal candidiasis. 35-0|이동↑]] Sobel JD. Recurrent vulvovaginal candidiasis. A prospective study of the efficacy of maintenance ketoconazole therapy. N Engl J Med 1986;315:1455-1458.
# [[질염#cite ref-Chronic or recurrent vaginal candidosis: short-term treatment and prophylaxis with itraconazole. 36-0|이동↑]] Creatsas GC, Charalambidis VM, Zagotzidou EH, Anthopoulou HN, Michailidis DC, Aravantinos DI. Chronic or recurrent vaginal candidosis: short-term treatment and prophylaxis with itraconazole. Clin Ther 1993;15:662-671.
# [[질염#cite ref-Managing recurrent vulvovaginal candidiasis. 37-0|이동↑]] Spinillo A, Colonna L, Piazzi G, Baltaro F, Monaco A, Ferrari A. Managing recurrent vulvovaginal candidiasis. Intermittent prevention with itraconazole. J Reprod Med 1997;42:83-87.
# [[질염#cite ref-Intermittent prophylactic treatment of recurrent vaginal candidiasis by postmenstrual application of a 500 mg clotrimazole vaginal tablet 38-0|이동↑]] Roth AC, Milsom I, Forssman L, Wahlen P. Intermittent prophylactic treatment of recurrent vaginal candidiasis by postmenstrual application of a 500 mg clotrimazole vaginal tablet. Genitourin Med 1990;66:357-360.
# ↑ <sup>[[질염#cite ref-Interventions for treating trichomoniasis in women. 39-0|이동:39.0]]</sup> <sup>[[질염#cite ref-Interventions for treating trichomoniasis in women. 39-1|39.1]]</sup> Forna F, Gulmezoglu AM. Interventions for treating trichomoniasis in women. Cochrane Database Syst Rev 2003;2:CD000218.
# [[질염#cite ref-Treatment of Trichomonas in pregnancy and adverse outcomes of pregnancy: a subanalysis of a randomized trial in Rakai.2C Uganda. 40-0|이동↑]] Kigozi GG, Brahmbhat H, Wabwire-Mangen F, et al. Treatment of Trichomonas in pregnancy and adverse outcomes of pregnancy: a subanalysis of a randomized trial in Rakai, Uganda. Am J Obstet Gynecol 2003;189:1398-1400.
# [[질염#cite ref-Interventions for trichomoniasis in pregnancy. 41-0|이동↑]] Gulmezoglu A. Interventions for trichomoniasis in pregnancy. Cochrane Database Syst Rev 2002;3:CD000220.
# [[질염#cite ref-Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. 42-0|이동↑]] Klebanoff MA, Carey JC, Hauth JC, et al. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N Engl J Med 2001;345:487-493.
# [[질염#cite ref-Prevalence of metronidazole-resistant Trichomonas vaginalis in a gynecology clinic. 43-0|이동↑]] Schmid G, Narcisi E, Mosure D, Secor WE, Higgins J, Moreno H. Prevalence of metronidazole-resistant Trichomonas vaginalis in a gynecology clinic. J Reprod Med 2001;46:545-549.